Systemic absorption of gallbladder sclerosing agents in the rabbit. A preliminary study

Area of Science:

• Gastroenterology
• Pharmacology
• Surgical Innovation

Background:

• Gallbladder sclerotherapy is an alternative treatment for gallbladder diseases.
• Ethanol and tetracycline are potential agents for gallbladder sclerosis.
• Systemic absorption and efficacy require evaluation.

Purpose of the Study:

• To measure systemic absorption of ethanol and tetracycline after gallbladder exposure in rabbits.
• To compare the efficacy of ethanol versus tetracycline as gallbladder sclerosing agents.

Main Methods:

• Systemic blood levels of ethanol and tetracycline were measured in 16 rabbits following gallbladder exposure.
• Gallbladder exposure times were 15 and 30 minutes.
• Efficacy was assessed by comparing sclerosing agent effectiveness.

Main Results:

• Maximal systemic ethanol level was 46 mg/dl; tetracycline was 4.6 micrograms/ml after 30 minutes.
• These serum levels are considered non-toxic in humans.
• Tetracycline (50 mg/cc) demonstrated slightly greater efficacy than 95% ethanol.

Conclusions:

• Tetracycline and ethanol show low systemic absorption, suggesting a good safety profile.
• Tetracycline appears to be a slightly more effective gallbladder sclerosing agent than ethanol in this rabbit model.